Intra-carotid artery brain metastasis models for the evaluation of lung and breast cancer drugs

Non-CNS metastatic brain cancer is approximately 10 times more common than CNS cancer. Lung cancer and breast cancer account for most brain metastasis. KRAS-mutant NSCLC composes a third lung adenocarcinoma, among which 17% to 55% will develop brain metastases. Likewise, more than a third HER2-positive breast cancer will develop brain metastasis. Among existing animal models, the ectopic injection in brain cannot reflect the mechanism of tumor invasion and metastasis, while tail vein and intra-cardiac injection usually produces extra-cerebral metastatic disease and the animals have to be sacrificed before brain metastases appears.

Intra-carotid artery brain metastasis models can provide a better observation opportunity compared to intra-cardiac models, and can better mimic the penetration through the blood brain barrier (BBB), compared to ectopic models.  We have developed a panel of intra-carotid artery brain metastatic models for drug evaluation, and demonstrated their superiority in growth kinetics and the brain microenvironment. These models can be a promising predictive tool for novel drug/modality discovery for targeting brain metastasis.



3 Brain metastasis ICA model_5988 _Fuyang

Download

← Return to Resources

Related Content

From April 25 to 30, 2025, the annual meeting of the American Association for Cancer Research (AACR), one of the...

VIEW RESOURCE

At this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...

VIEW RESOURCE
← View all in vivo Pharmacology Resources
× peptide, amino acid

Contact An Expert Today!